Search Results

Celerion, a leading clinical research organization, is pleased to announce it has received a CRO Leadership Award for the ninth time by global biopharmaceutical executives in Life Science Leader’s annual CRO Leadership Awards for 2024.

Celerion , a leading clinical research organization, proudly announces its recent achievement of obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification for its state-of-the-art bioanalytical laboratory located in Lincoln, Nebraska.

Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, announces the expansion of molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards to support the development of new modality therapies, such as cell and gene therapies.

Celerion, a clinical research organization to the biopharmaceutical industry, has announced completion of additions to its research capacity and services.

Celerion , a leading clinical research organization (CRO) provider to the biopharmaceutical industry, will deliver a key address on the final day of the V

Clinical research organization Celerion today announced its successful reaccreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

A rich history of providing early clinical research services to the pharmaceutical industry has proven Celerion a leader in helping bring new drugs to market.

Celerion announced today the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities demonstrating their commitment to further assisting sponsors in meeting the regulatory requirements to characterize and quantify drug metabolites and their potential for impacting drug effect as part of the process to becoming an approved therapeutic product. Celerion has created a compelling bioanalytical

Nebraska Innovation Campus has announced a new partner. Dan Duncan, NIC’s executive director, said Celerion will move into this space on the campus in February of 2020.

Celerion is proud to announce, for the fifth consecutive year, recognition of its early stage research development services across five categories in the 2020 CRO Leadership Awards sponsored by Life Science Leader and Industry Standard Research. Both small and large pharma respondents highlighted Celerion as a top performer in categories including Capabilities, Compatibility, Expertise, and Quality . Importantly,